NexImmune, Inc.
NEXI · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $2 | $6 | $105 | $576 |
| - Cash | $3 | $35 | $30 | $5 |
| + Debt | $0 | $1 | $0 | $19 |
| Enterprise Value | -$1 | -$28 | $75 | $591 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$28 | -$61 | -$49 | -$28 |
| % Margin | – | – | – | – |
| Net Income | -$32 | $514 | -$52 | -$32 |
| % Margin | – | – | – | – |
| EPS Diluted | -30.82 | 534.29 | -56.67 | -34.76 |
| % Growth | -105.8% | 1,042.8% | -63% | – |
| Operating Cash Flow | -$31 | -$51 | -$46 | -$26 |
| Capital Expenditures | -$0 | -$1 | -$2 | -$1 |
| Free Cash Flow | -$31 | -$52 | -$48 | -$27 |